Molecular Point-of-care Testing for Influenza A/B and Respiratory Syncytial Virus: Workflow Parameters for the ID Now™ and cobas® Liat® Systems
Main Authors: | S. Young, J. Phillips, C. Griego-Fullbright, A. Wagner, P. Jim, S. Chaudhuri, S. Tang, J. Sickler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Journal of Infection and Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034120301763 |
Similar Items
-
Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.
by: Paul A Granato, et al.
Published: (2018-01-01) -
Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care.
by: Hiroshige Mikamo, et al.
Published: (2022-01-01) -
Performance of ID NOW Influenza A&B 2
by: Susana Bandarra, et al.
Published: (2023-08-01) -
Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples
by: Maxime Veillette, et al.
Published: (2022-11-01) -
Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?
by: Alessandro Rocca, et al.
Published: (2021-04-01)